NEOGEN CHEMICALS

    NEOGEN
    Chemicals
    ₹2,780.20
    Price as of 18 Nov 2026, 9:58 pm IST

    Market cap ₹8,352 Cr

    P/E
    193.61
    Day range
    ₹2,686.00 – ₹2,832.00
    52-week range
    ₹966.70 – ₹2,875.00
    Volume
    7.45 L
    Open
    ₹2,764.80
    Prev close
    ₹2,778.60

    Latest results · Q2 FY27(consolidated)Revenue ₹296 Cr+41.8%Profit ₹8 Cr+144.2%Margin 2.8%YoY vs the same quarter last year

    1 red flag to read up on

    • medium

      Promoter holding falling

      48.31%, down 2.92 pts since 2026-03-31 · 30 Sept 2026

    From NSE and BSE filings. A flag is a reason to read the filing, not a rating.

    Research profile

    Composite 45 / 100

    Factor percentiles

    Value17
    Quality29
    Momentum96
    Low volatility36

    Derived metrics

    Earn. yield
    0.5%
    Graham no.
    ₹406.24
    vs Graham
    -85.4%
    ROE ÷ P/B
    0.7%
    12-1 mom.
    +89.9%
    Return / vol
    2.24
    Magic Formula
    #610
    Piotroski
    4/6
    FCF yield
    -9.4%
    PEG
    1.34

    Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.

    Peer comparison

    All 44 in Chemicals
    Largest Chemicals companies tracked, with sector medians
    CompanyM-capP/EP/BROEROCEOPMD/ESales YoY
    Solar IndustriesSOLARINDS₹1.68 L Cr74.0422.1932.5%38.0%29.0%0.23+69.0%
    Pidilite IndustriesPIDILITIND₹1.56 L Cr58.1214.0524.0%31.0%20.0%0.03+20.9%
    SRF LtdSRF₹72,471 Cr31.754.8013.8%15.0%19.0%0.35+34.7%
    Linde IndiaLINDEINDIA₹58,548 Cr118.4613.4213.6%18.0%32.0%0.23+12.3%
    Coromandel InternationalCOROMANDEL₹57,701 Cr37.014.3016.1%22.0%9.0%0.12+6.6%
    Gujarat FluorochemicalsFLUOROCHEM₹52,952 Cr78.396.177.6%10.0%27.0%0.28+45.5%
    Navin Fluorine InternationalNAVINFLUOR₹52,759 Cr57.9511.3720.1%21.0%34.0%0.28+57.1%
    NEOGEN CHEMICALSNEOGEN₹8,352 Cr193.615.093.6%6.0%15.3%1.04+41.8%
    Sector median₹13,505 Cr31.752.869.9%12.0%15.7%0.27+21.5%

    Sector as classified in the tracked universe; medians use every tracked Chemicals company, and P/E only profitable ones. Tinted figures beat the median.

    Latest news

    Updated 9h ago

    Headlines about NEOGEN CHEMICALS from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.

    Key metrics

    P/E (TTM)
    199.0
    Price / Book
    5.30
    ROE (FY26)
    3.6%
    ROCE (latest year)
    6%
    Dividend yield
    0.04%

    Moving averages (NSE)

    20-day
    ₹2,433.57
    Price above
    50-day
    ₹2,409.43
    Price above
    200-day
    ₹1,896.99
    Price above

    Charts & trends

    From company filings. Amounts in ₹ crore.

    Revenue 3Y CAGR
    +7.9%
    Profit 3Y CAGR
    -16.6%
    Revenue YoY (Sep 2026)
    +41.8%
    Profit YoY (Sep 2026)
    +144.2%
    Operating margin
    15.3%
    Net margin
    2.8%

    Revenue, profit & margin - quarterly

    ₹ crore; a loss shows red. Operating margin below, same periods.

    0 Cr100 Cr200 Cr300 Cr
    • Revenue
    • Net profit

    Operating margin

    Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Sep 20260%10%20%

    Who owns the company

    % of equity by quarter, latest Sept 2026

    Dec '24Mar '25Jun '25Sept '25Dec '25Mar '26Jun '26Sept '260%25%50%75%100%
    • Promoter
    • Public
    • DII
    • FII

    Cash flows

    Where cash came from and went, by fiscal year (₹ crore)

    Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-1K Cr-500 Cr0 Cr500 Cr1K Cr
    • Operating
    • Investing
    • Financing
    • Free cash flow

    Return on equity

    Net profit over shareholders' equity, by fiscal year

    FY17FY18FY19FY20FY21FY22FY23FY24FY25FY260%10%20%30%40%15% screen

    Equity vs debt

    Shareholders' equity against borrowings (₹ crore); the ratio below, same years.

    0 Cr500 Cr1K Cr1.5K Cr2K Cr
    • Equity
    • Debt

    Debt to equity

    Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 20260x1x2x

    Dividends per share

    ₹ by fiscal year of the ex-date; the latest year runs to date.

    FY21FY22FY23FY24FY25₹0₹1₹2₹3

    Financial statements

    ₹ Crore
    Quarterly results, oldest period first, figures in rupees crore
    Line itemDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
    Sales164.44199.65179.95193.36201.43202.82186.73208.66220.02246.56250.29295.96
    YoY Sales growth-11.71-2.09——————————
    Expenses144.15163.86149.15158.85166.79166.44155.22178.70188.12202.65202.06250.64
    Operating Profit20.2935.7930.8034.5134.6436.3831.5129.9631.9043.9148.2345.32
    OPM %12.3%17.9%17.1%17.9%17.2%17.9%16.9%14.4%14.5%17.8%19.3%15.3%
    Other Income1.672.231.590.841.14-13.441.231.982.201.014.063.97
    Interest10.529.699.8212.7513.4312.5012.6719.4821.5121.4720.8127.78
    Depreciation5.745.866.817.127.106.765.787.316.837.608.208.79
    Profit before tax5.7022.4715.7615.4815.253.6814.295.155.7615.8523.2812.72
    Tax %81.4%24.7%27.2%29.2%34.4%34.5%28.2%34.6%35.9%28.1%26.5%35.3%
    Net Profit1.0616.9311.4710.9610.012.4110.263.373.6911.3917.118.23
    EPS in Rs₹0.40₹6.42₹4.35₹4.15₹3.79₹0.91₹3.89₹1.28₹1.40₹4.32₹6.25₹2.74

    From company filings, updated 17 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.

    Working-capital cycle

    Debtor Days161

    +76 days since Mar 2021

    Inventory Days445

    +234 days since Mar 2021

    Days Payable346

    +224 days since Mar 2021

    Cash Conversion Cycle260

    +86 days since Mar 2021

    Working Capital Days85

    +19 days since Mar 2021

    Strengths, risks & growth

    Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]

    Strengths

    • Company is expected to give good quarter
    • Company's median sales growth is 20.3% of last 10 years
    • Company's working capital requirements have reduced from 112 days to 84.6 days

    Risks

    • Stock is trading at 5.09 times its book value
    • Company has low interest coverage ratio.
    • Promoter holding has decreased over last quarter: -4.69%
    • Company has a low return on equity of 4.90% over last 3 years.
    • Dividend payout has been low at 13.6% of profits over last 3 years
    • Company has high debtors of 161 days.

    Compounded Sales Growth

    10 Years
    +24%
    5 Years
    +21%
    3 Years
    +8%
    TTM
    +27%

    Compounded Profit Growth

    10 Years
    +19%
    5 Years
    -2%
    3 Years
    -17%
    TTM
    +23%

    Stock Price CAGR

    10 Years
    —
    5 Years
    +15%
    3 Years
    +20%
    1 Year
    +101%

    Return on Equity

    10 Years
    +9%
    5 Years
    +7%
    3 Years
    +5%
    Last Year
    +4%

    Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.

    Shareholding pattern

    Percentage of shares held by each category at each quarter end
    HolderDec 2025Mar 2026Jun 2026Sept 2026Change
    Promoter51.22%51.22%53.00%48.31%-4.69 pp
    FII4.57%4.46%4.11%4.13%+0.02 pp
    DII21.99%22.65%19.60%23.48%+3.88 pp
    Public22.21%21.67%23.27%24.07%+0.80 pp

    Filed with NSE for Sept 2026: promoters 48.31%, public 51.69%

    Analysts & fund holdings

    82%
    82% recommend buy
    11 analysts cover the stock
    Valuation vs Chemicals
    P/E193.6 vs 25.1
    Sector P/B3.02
    Beta1.17

    Who holds the shares, quarter by quarter

    Mutual funds 16.51% (+0.74 pp)
    Sept 25
    Dec 25
    Mar 26
    Apr 26
    Jun 26
    Sept 26
    • Promoters48.3%
    • Foreign institutions4.1%
    • Mutual funds16.5%
    • Insurance2.7%
    • Other domestic institutions4.3%
    • Retail14.9%
    • Others9.2%
    Mutual funds holding the most
    Fund% of company% of fund3-month change
    SBI Contra Fund3.42%0.61%+0.09 pp
    Axis Small Cap Fund2.47%0.68%+0.14 pp
    Invesco India Smallcap Fund1.48%0.73%+0.42 pp
    ICICI Pru Multi Cap Fund0.89%0.40%+0.40 pp
    JM Flexi Cap Fund0.65%1.03%+0.57 pp

    Scorecard

    Performance
    Avg
    Valuation
    High
    Growth
    Low
    Profitability
    Avg
    Entry point
    Avg
    Red flags
    Low

    Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.

    Risk & trend

    From 292 daily sessions to 18 Nov 2026.

    Computed

    Risk

    Volatility (1Y)
    50.3%
    Downside volatility
    47.3%
    Worst 5% of days
    5.3%
    Average of that tail
    6.7%
    Max drawdown (1Y)
    38.5%
    Below its peak
    2.7%

    Against the market

    Beta vs Nifty 50
    0.89
    Correlation
    0.24
    Relative strength (3M)
    +18.6%
    ATR (14)
    5.0%

    Return

    Return 1M
    +11.9%
    Return 3M
    +22.5%
    Return 6M
    +64.4%
    Return 1Y
    +112.5%
    vs 200-day average
    +46.6%

    Momentum

    RSI (14)
    63.7
    MACD histogram
    47.31
    Stochastic %K
    88.9
    ADX (14)
    25.4
    +DI / −DI
    30.5 / 16.6
    Money flow index
    84.0

    Participation

    Delivery (20d avg)
    43.8%
    vs its 60-day baseline
    +1.4 pts
    Volume vs 20-day
    +7.0σ
    Close vs day's VWAP
    +0.0%
    52-week position
    96 / 100

    These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.

    Financial quality

    From consolidated statements to 30 Sept 2026.

    Computed

    Piotroski F-Score

    4 of 6 tested

    • Return on assets positive — passed
    • Operating cash flow positive — not testableno cash flow statement for this period
    • Return on assets improving — passed
    • Cash flow exceeds profit — not testableneeds cash flow and profit against assets
    • Debt to assets falling — passed
    • Current ratio improving — failed
    • No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
    • Operating margin improving — passed
    • Asset turnover improving — failed
    Free cash flow
    -₹787 Cr
    FCF yield
    -9.4%
    Cash conversion
    -8.06
    Accruals ratio
    0.090
    Net debt
    ₹1,196 Cr
    Net debt / equity
    0.76
    EV / sales
    9.43
    PEG
    1.34
    Capex intensity
    64.5%
    Revenue CAGR
    28.6%
    Profit CAGR
    126.6%

    Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.

    Insider trades

    Last 12 months, market trades
    Net buying ₹160 Cr
    5 buys · ₹161 Cr
    7 sells · ₹1.2 Cr
    Latest insider trades disclosed to NSE
    PersonTypeSharesValueDisclosed
    SANJAY NATWARLAL MEHTA HUF
    Other · Market Sale
    Sell61₹1.5 L7 Nov 2026
    SANJAY NATWARLAL MEHTA HUF
    Other · Market Sale
    Sell2,300₹57.1 L7 Nov 2026
    SANJAY NATWARLAL MEHTA HUF
    Other · Market Sale
    Sell61₹1.5 L7 Nov 2026
    SANJAY NATWARLAL MEHTA HUF
    Other · Market Sale
    Sell2,300₹57.1 L7 Nov 2026
    HEENA HITESH RESHAMWALA
    Other · Gift
    Sell354₹029 Aug 2026
    VIREN BHARATKUMAR RESHAMWALA .
    Other · Gift
    Buy354₹029 Aug 2026
    CADAMBA SOLUTIONS PRIVATE LIMITED
    Promoter Group · Preferential Offer
    Buy10,00,000₹161 Cr20 Apr 2026
    HARIN HARIDAS KANANI
    Promoters · Pledge Creation
    Pledge20,19,167₹013 Apr 2026
    HARIN HARIDAS KANANI
    Promoters · Pledge Creation
    Pledge13,19,083₹030 Mar 2026
    Haridas Kanani Family Trust
    Promoters · Gift
    Buy52,76,500₹02 Jan 2026
    HARIDAS THAKARSHI KANANI
    Promoters · Gift
    Sell57,78,500₹02 Jan 2026
    BEENA HARIDAS KANANI
    Promoter Group · Gift
    Sell26,38,250₹02 Jan 2026

    Disclosures filed with NSE under SEBI (Prohibition of Insider Trading) Regulations. Pledges and releases are not trades and are not counted above.

    Corporate actions

    • dividend
      Not available — not reported in this filing

      Dividend - Re 1 Per Share

      13 Aug 2026
      ex-date
    • dividend
      Not available — not reported in this filing

      Dividend - Re 1 Per Share

      19 Sept 2025
      ex-date
    • dividend
      ₹2.00

      Annual General Meeting/Dividend - Rs 2 Per Share

      19 Sept 2024
      ex-date
    • other
      Not available — not reported in this filing

      Extra Ordinary General Meeting

      20 Oct 2023
      ex-date
    • dividend
      ₹3.00

      Annual General Meeting/Dividend - Rs 3 Per Share

      25 Aug 2023
      ex-date
    • dividend
      ₹2.75

      Annual General Meeting/Dividend - Rs 2.75 Per Share

      19 Sept 2022
      ex-date
    • other
      Not available — not reported in this filing

      Extra-Ordinary General Meting

      23 Dec 2021
      ex-date
    • dividend
      ₹2.25

      Dividend - Rs 2.25 Per Share

      16 Sept 2021
      ex-date
    • dividend
      ₹2.00

      Annual General Meeting/Dividend - Rs 2 Per Share

      17 Sept 2020
      ex-date
    • dividend
      ₹1.50

      Dividend - Rs 1.50 Per Share

      11 Sept 2019
      ex-date

    Company announcements

    Company Update
    Disclosure Pursuant To Regulation 30(9) Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    Disclosure pertaining to approval by the Board of Neogen Morita New Materials Limited (NML) for issuance of equity shares of NML on Preferential Issue basis.

    Company UpdatePrice-sensitive
    Announcement under Regulation 30 (LODR)-Credit Rating

    Intimation of credit rating.

    Insider Trading / SAST
    Closure of Trading Window

    Intimation of closure of trading window

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Intimation of Analyst/Investor meet to be held on September 28, 2026.

    Company Update
    Announcement under Regulation 30 (LODR)-Press Release / Media Release

    Press Release titled " Neogen Chemicals raises approx INR 600 crore via its first ever QIP; Issue oversubscribed by 6.5x

    Company Update
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Intimation of Analyst/Investor meeting to be held on September 22, 2026.

    Company Update
    Outcome Of The Meeting Of The Fund-Raising Committee Held On September 16, 2026

    Outcome of Fund raising Committee meeting approving allotment of equity shares on QIP basis.

    Company Update
    Announcement under Regulation 30 (LODR)-Allotment

    Outcome of fund raising committee approving allotment of equity shares on QIP basis.

    Company Update
    Announcement under Regulation 30 (LODR)-Qualified Institutional Placement

    Outcome of Fund raising committee approving allotment of equity shares on QIP basis

    Company Update
    Outcome Of Fund Raising Committee

    Outcome of Fund raising committee held today approving closure of issue, issue price, placement document, and confirmation of allocation note

    Company Update
    Announcement under Regulation 30 (LODR)-Qualified Institutional Placement

    Outcome of Fund Raising Committee held today approving closure of issue, issue price, placement document and confirmation of allocation note.

    Company Update
    Outcome Of Fund Raising Committee Meeting Held Today

    Approval of Issue opening date and Floor price and PPD.

    Company Update
    Announcement under Regulation 30 (LODR)-Qualified Institutional Placement

    Outcome of Fund raising committee meeting held today for opening of QIP issue.

    Company Update
    Disclosure Under Regulation 30 And 51(2) Read With Schedule III Of The SEBI LODR - Show Cause Cum Demand Notice

    Show Cause cum Demand Notice received from Office of the Commissioner CGST.

    Company Update
    Disclosure Pursuant To Regulation 30 (9) Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').

    Approval for execution of Business Transfer Agreement between NIL and NML for sale/ transfer of undertaking/ assets as mentioned in detail in BTA by NIL to NML.

    Filed with BSE (scrip 542665); the last 45 days. Documents open at bseindia.com.

    SEBI filings & orders

    From SEBI's website. An order may concern the company, its officers or trading in its shares, and may be under appeal - read the order itself. Personal identifiers are withheld.

    Regulatory orders

    • Order

      Exemption order in the matter of Neogen Chemicals Ltd.

      30 Dec 2025
      Read on SEBI

    Documents

    Credit ratings

    Documents open at BSE or the rating agency that issued them.

    Sourced from the company's NSE XBRL filing dated 1 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.

    FAQ

    NEOGEN CHEMICALS: common questions

    Answered from the figures on this page.

    NEOGEN CHEMICALS last traded at ₹2,780.20 (NSE, as of 18 Nov 2026). The last session moved it up 0.06%.

    NEOGEN CHEMICALS is valued at about ₹8,352 crore (NSE, as of 18 Nov 2026).

    NEOGEN CHEMICALS trades at a price-to-earnings ratio of 193.61 (NSE, as of 18 Nov 2026). The P/E compares the share price with earnings per share, so it is only comparable between companies in the same industry.

    NEOGEN CHEMICALS has traded between ₹966.70 and ₹2,875.00 over the past 52 weeks, to 18 Nov 2026. It is currently 95% of the way up that range.

    NEOGEN CHEMICALS (NEOGEN) is classified under Chemicals on this site's screener.